← Open Payments lookup

PAMELA PALMER: Open Payments

NPI 1205298023 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,346 in 63 payments from 15 companies in 2025. Trend: 2023 $1,034 · 2024 $1,176 · 2025 $1,346

Food & beverage: $1,085Consulting: $150Education: $111
CompanyPaymentsAmount
ABBVIE INC.23$424
Neurocrine BioSciences, Inc.18$287
Teva Pharmaceuticals USA, Inc.7$203
Biogen, Inc.1$150
ARGENX US, INC.2$46
Vifor Pharma, Inc.2$36
Fresenius USA Marketing, Inc.2$35
Takeda Pharmaceuticals U.S.A., Inc.1$33
Genentech USA, Inc.1$29
Lilly USA, LLC1$20

Products named: INGREZZA, QULIPTA, TYSABRI, AUSTEDO XR, UBRELVY, CREON, Veltassa, VELPHORO.

Industry payments across NE — which companies pay providers there.